Telpegfilgrastim

拓培非格司亭

Report date: 2025/04/17 17:53:20

Base Information

Drug NameTelpegfilgrastim
Drug Alias NameYPEG-filgrastimY型PEG化重组人粒细胞刺激因子Y-shaped pegylated filgrastimY-shaped branched pegylated filgrastimTelpegfilgrastim injection +[10] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsIdiopathic short statureFebrile NeutropeniaNeutropenia +[4] 
Global Approved IndicationsFebrile Neutropenia
Approved Indications in ChinaFebrile Neutropenia
Original Approved Country/TerritoryMainland China
Original Approved Date2023/06/30
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesXiamen Amoytop Biotech Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesXiamen Amoytop Biotech Co LtdSun Yat-Sen UniversityXiamen Bosai Gene Transcription Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsIdiopathic short statureFebrile NeutropeniaNeutropenia +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A